AxoGen, Inc. ( AXGN) - Key Metrics
AXGN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.31 | -$0.03 | $0.03 | $0.01 |
| 2026Q1 | $1.19 | -$0.38 | $0.03 | -$0.02 |
| 2025Q4 | $1.28 | -$0.28 | $0.06 | $0.04 |
| 2025Q3 | $1.31 | $0.02 | $0.07 | $0.03 |
| 2025Q2 | $1.24 | $0.01 | $0.17 | $0.15 |
AXGN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -384.92 |
| 2026Q1 | 0% | -21.80 |
| 2025Q4 | 0% | -29.22 |
| 2025Q3 | 0% | 293.42 |
| 2025Q2 | 0% | 215.28 |
AXGN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.02% | 0% |
| 2026Q1 | -0.07% | 0% |
| 2025Q4 | 0.12% | 0% |
| 2025Q3 | 0.17% | 0% |
| 2025Q2 | 1.42% | 0% |
AXGN
Price: $48.73
52 week price:
Dividend Yield: 2.25%
Payout Ratio Range:
Earnings Per Share: -0.68 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 233500
Ebitda: -1.4 millionMarket Capitalization: 2.4 billion